Financhill
Sell
26

CSTL Quote, Financials, Valuation and Earnings

Last price:
$26.87
Seasonality move :
-4.36%
Day range:
$27.04 - $28.01
52-week range:
$16.97 - $35.84
Dividend yield:
0%
P/E ratio:
129.05x
P/S ratio:
2.45x
P/B ratio:
1.72x
Volume:
234.4K
Avg. volume:
323.1K
1-year change:
23.58%
Market cap:
$759M
Revenue:
$219.8M
EPS (TTM):
$0.21

Earnings Data

Next earnings date for CSTL
Feb 28
2025
Most recent earnings per share
$0.08
Beat by $0.07
(Nov 4/2024)
Consensus Estimate
$0.01
(Nov 4/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CSTL Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/28/2025 Q4 $80.4M -- -- $0.01 --
11/04/2024 Q3 $79M $85.8M $0.08 $0.01 $0.07
08/05/2024 Q2 $69.4M $87M $0.31 -$0.25 $0.56
05/02/2024 Q1 $66.2M $73M -$0.09 -$0.31 $0.22
02/28/2024 Q4 $61.2M $66.1M -$0.09 -$0.49 $0.40
11/02/2023 Q3 -- -- -$0.26 -$0.73 $0.47
08/02/2023 Q2 -- -- -$0.70 -$0.91 $0.21
05/03/2023 Q1 -- -- -$1.10 -$0.89 -$0.21
02/28/2023 Q4 -- -- -$0.78 -$0.83 $0.05
11/02/2022 Q3 -- -- -$0.77 -$0.97 $0.20
08/08/2022 Q2 -- -- -$0.06 -$0.80 $0.74
05/09/2022 Q1 -- -- -$0.97 -$0.74 -$0.23
02/28/2022 Q4 -- -- -$0.25 -$0.47 $0.22
11/08/2021 Q3 -- -- -$0.47 -$0.37 -$0.10
08/09/2021 Q2 -- -- -$0.35 -$0.39 $0.04
05/10/2021 Q1 -- -- -$0.17 -$0.19 $0.02
03/08/2021 Q4 -- -- -$0.23 -$0.11 -$0.12
11/09/2020 Q3 -- -- -$0.23 -$0.16 -$0.08
08/10/2020 Q2 -- -- -$0.08 -$0.44 $0.36
05/11/2020 Q1 -- -- $0.03 -$0.05 $0.08
03/10/2020 Q4 -- -- $0.11 -$0.02 $0.13
11/11/2019 Q3 -- -- $0.05 -$0.30 $0.35
09/03/2019 Q2 -- -- -$0.15 -$0.47 $0.32
03/31/2019 Q1 -- -- -$0.22 -- --
12/31/2018 Q4 -- -- $0.27 -- --
09/30/2018 Q3 -- -- -$0.42 -- --
06/30/2018 Q2 -- -- -$0.38 -- --
03/31/2018 Q1 -- -- -$0.42 -- --

Castle Biosciences Earnings Questions

  • How Much did Castle Biosciences Generate in Revenue Last Quarter?

    Castle Biosciences reported $85.8M worth of top line sales in its most recent quarter.

  • Did Castle Biosciences Beat Earnings Last Quarter?

    Castle Biosciences announced earnings per share of $0.08 which represents a beat of analyst forecast a $0.01 per share.

  • Is Castle Biosciences Profitable?

    Castle Biosciences reported $70.2M that represents $2.39 per share over the last quarter.

  • What is the Analyst Consensus for Castle Biosciences EPS Next Year?

    Castle Biosciences's earnings are forecast to decrease from -$2.14 per share to -$2.53 per share next year representing a decrease of -75.63%.

  • When is Castle Biosciences's Earnings Date?

    Castle Biosciences's next earnings date is February 28, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Uber Stock a Buy on the Dip?
Is Uber Stock a Buy on the Dip?

Shares of Uber Technologies (NYSE:UBER) have been fading fast in…

Is AMD Stock an All-Time Buy?
Is AMD Stock an All-Time Buy?

Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…

How High Will Airbnb Stock Go?
How High Will Airbnb Stock Go?

Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 43x

Buy
56
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Buy
57
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Alerts

Buy
64
ARQQ alert for Dec 27

Arqit Quantum [ARQQ] is down 3.22% over the past day.

Buy
64
QMCO alert for Dec 27

Quantum [QMCO] is up 4.72% over the past day.

Buy
65
ALGS alert for Dec 27

Aligos Therapeutics [ALGS] is down 4.82% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock